Form 4 for KYNB KYNTRA BIO, INC.
Accepted 2026-09-09 20:42:29 ET · period of report 2026-09-06 · accession 0001815638-26-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-09 20:42 | 2026-09-06 | KYNB | Wettig Thane | CEO, Dir | F - Tax | $8.55 | -209 | 26.8K | -0.8% | -$1,787 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-06 | F | D | 209 | $8.55 | 26,796 | D | — | — | (F1) Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units |